{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:07:15Z","timestamp":1779376035289,"version":"3.53.1"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.cca.2018.05.057","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T16:27:12Z","timestamp":1527870432000},"page":"197-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Effect of uremic toxin-indoxyl sulfate on the skeletal system"],"prefix":"10.1016","volume":"484","author":[{"given":"Wen-Chih","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paik-Seong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiaw-Wen","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chou","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Mei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fwu","family":"Shyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cca.2018.05.057_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00774-014-0639-x","article-title":"Chronic kidney disease and bone metabolism","volume":"33","author":"Kazama","year":"2015","journal-title":"J. Bone Miner. Metab."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI37672","article-title":"Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure","volume":"120","author":"D'apolito","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0015","first-page":"96","article-title":"Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis","volume":"124","author":"Niwa","year":"1994","journal-title":"J. Lab. Clin. Med."},{"issue":"8","key":"10.1016\/j.cca.2018.05.057_bb0020","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Nii-Kono","year":"2007","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/kisup.2013.93","article-title":"Uremic osteoporosis","volume":"3","author":"Kazama","year":"2013","journal-title":"Kidney Int. Suppl."},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00774-005-0667-7","article-title":"Uremic toxin and bone metabolism","volume":"24","author":"Iwasaki","year":"2006","journal-title":"J. Bone Miner. Metab."},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0035","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bone.2011.03.672","article-title":"Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease","volume":"48","author":"Iwasaki","year":"2011","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bone.2013.07.037","article-title":"Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease","volume":"57","author":"Iwasaki","year":"2013","journal-title":"Bone"},{"issue":"1\u20132","key":"10.1016\/j.cca.2018.05.057_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(03)01530-9","article-title":"Interactions of human organic anion as well as cation transporters with indoxyl sulfate","volume":"466","author":"Enomoto","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.bjp.0704482","article-title":"Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake","volume":"135","author":"Motojima","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0055","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1523-1755.2003.00906.x","article-title":"Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-\u03baB and free radical in proximal tubular cells","volume":"63","author":"Motojima","year":"2003","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2050-6511-14-60","article-title":"Indoxyl sulfate promotes apoptosis in cultured osteoblast cells","volume":"14","author":"Kim","year":"2013","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0065","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/ndt\/gfr647","article-title":"Indoxyl sulphate inhibits osteoclast differentiation and function","volume":"27","author":"Mozar","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.cca.2018.05.057_bb0070","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevEukarGeneExpr.v18.i3.20","article-title":"The aryl hydrocarbon receptor complex and the control of gene expression","volume":"18","author":"Beischlag","year":"2008","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"12","key":"10.1016\/j.cca.2018.05.057_bb0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrc3846","article-title":"Aryl hydrocarbon receptor ligands in cancer: friend and foe","volume":"14","author":"Murray","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.cca.2018.05.057_bb0080","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.4049\/jimmunol.1600822","article-title":"The nuclear receptor AhR controls bone homeostasis by regulating osteoclast differentiation via the RANK\/c-Fos signaling axis","volume":"197","author":"Izawa","year":"2016","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcp.2003.08.038","article-title":"Inhibition of osteoclast formation by 3-methylcholanthrene, a ligand for arylhydrocarbon receptor: suppression of osteoclast differentiation factor in osteogenic cells","volume":"67","author":"Naruse","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.cca.2018.05.057_bb0090","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1006\/bbrc.2000.4226","article-title":"Severely reduced production of klotho in human chronic renal failure kidney","volume":"280","author":"Koh","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Dr\u00fceke","year":"2016","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cca.2018.05.057_bb0100","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1681\/ASN.V34947","article-title":"Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity","volume":"3","author":"Hsu","year":"1992","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI118061","article-title":"Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins","volume":"96","author":"Patel","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.cca.2018.05.057_bb0110","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/nep.12673","article-title":"Upregulation of nuclear factor-\u03baB activity mediates CYP24 expression and reactive oxygen species production in indoxyl sulfate-induced chronic kidney disease","volume":"21","author":"Wang","year":"2016","journal-title":"Nephrology"},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0115","doi-asserted-by":"crossref","first-page":"E1636","DOI":"10.1152\/ajpendo.00396.2007","article-title":"Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice","volume":"293","author":"Liu","year":"2007","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0120","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.cca.2018.05.057_bb0125","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MAJ.0b013e3182989f26","article-title":"Association of indoxyl sulfate with fibroblast growth factor 23 in patients with advanced chronic kidney disease","volume":"347","author":"Lin","year":"2014","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.cca.2018.05.057_bb0135","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2215\/CJN.02680310","article-title":"Reciprocal control of 1, 25-dihydroxyvitamin D and FGF23 formation involving the FGF23\/Klotho system","volume":"5","author":"Pri\u00e9","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2018.05.057_bb0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","article-title":"The chronic kidney disease\u2014mineral bone disorder (CKD-MBD): advances in pathophysiology","volume":"100","author":"Hruska","year":"2017","journal-title":"Bone"},{"issue":"4 Suppl 3","key":"10.1016\/j.cca.2018.05.057_bb0145","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ckj\/sfx116","article-title":"CKD-MBD KDIGO guidelines: how difficult is reaching the \u2018target\u2019?","volume":"11","author":"Cozzolino","year":"2018","journal-title":"Clin. Kidney J."},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0155","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ki.1994.276","article-title":"The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia","volume":"46","author":"Bover","year":"1994","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.cca.2018.05.057_bb0160","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","article-title":"Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone","volume":"20","author":"Iwasaki-Ishizuka","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0165","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cca.2018.05.057_bb0170","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","article-title":"Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure","volume":"58","author":"Picton","year":"2000","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0175","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.cca.2018.05.057_bb0180","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/jbmr.494","article-title":"Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting","volume":"26","author":"Alonso","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endo.143.1.8575","article-title":"Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH\/PTHrP receptor","volume":"143","author":"Divieti","year":"2002","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.cca.2018.05.057_bb0190","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0195","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/ki.1995.248","article-title":"Parathyroidectomy does not prevent the renal PTH\/PTHrP receptor down-regulation in uremic rats","volume":"47","author":"Urena","year":"1995","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.cca.2018.05.057_bb0200","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","article-title":"Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure","volume":"39","author":"Kazama","year":"2002","journal-title":"Am. J. Kidney Dis."},{"issue":"8","key":"10.1016\/j.cca.2018.05.057_bb0205","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/BF03347242","article-title":"Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis","volume":"28","author":"Gonnelli","year":"2005","journal-title":"J. Endocrinol. Investig."},{"issue":"11","key":"10.1016\/j.cca.2018.05.057_bb0210","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/ndt\/13.11.2755","article-title":"New concepts in renal osteodystrophy","volume":"13","author":"Hruska","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1495","key":"10.1016\/j.cca.2018.05.057_bb0215","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1098\/rstb.2007.2251","article-title":"From individual Wnt pathways towards a Wnt signalling network","volume":"363","author":"Kestler","year":"2008","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0220","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a002881","article-title":"Wnt signaling from development to disease: insights from model systems","volume":"1","author":"Cadigan","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cca.2018.05.057_bb0225","series-title":"Current Topics in Developmental Biology","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/B978-0-12-385044-7.00007-2","article-title":"Planar cell polarity signaling in the Drosophila eye","volume":"vol. 93","author":"Jenny","year":"2010"},{"issue":"3\u20134","key":"10.1016\/j.cca.2018.05.057_bb0230","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ceca.2005.06.022","article-title":"Wnt and calcium signaling: \u03b2-catenin-independent pathways","volume":"38","author":"Kohn","year":"2005","journal-title":"Cell Calcium"},{"issue":"10","key":"10.1016\/j.cca.2018.05.057_bb0235","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/jbmr.118","article-title":"Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells","volume":"25","author":"Stevens","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2011.10.044","article-title":"Update on Wnt signaling in bone cell biology and bone disease","volume":"492","author":"Monroe","year":"2012","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0245","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diab. Endocrinol."},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0250","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2015.156","article-title":"Sclerostin and DKK1: new players in renal bone and vascular disease","volume":"88","author":"Evenepoel","year":"2015","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2018.05.057_bb0260","series-title":"Seminars in Dialysis: 2015","first-page":"578","article-title":"Sclerostin, osteocytes, and chronic kidney disease\u2013mineral bone disorder","author":"Moys\u00e9s","year":"2015"},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0265","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nephro.2014.04.002","article-title":"Group EUTW: uremic toxicity and sclerostin in chronic kidney disease patients","volume":"10","author":"Desjardins","year":"2014","journal-title":"Nephrol. Ther."},{"issue":"15","key":"10.1016\/j.cca.2018.05.057_bb0270","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","article-title":"Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium","volume":"110","author":"Ryan","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.cca.2018.05.057_bb0275","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0280","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"Ke","year":"2012","journal-title":"Endocr. Rev."},{"issue":"26","key":"10.1016\/j.cca.2018.05.057_bb0285","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0290","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.jrn.2010.05.002","article-title":"Indoxyl sulfate is a nephro-vascular toxin","volume":"20","author":"Niwa","year":"2010","journal-title":"J. Ren. Nutr."},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019595","article-title":"The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.cca.2018.05.057_bb0300","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jc.2013-1521","article-title":"Sclerostin: another vascular calcification inhibitor?","volume":"98","author":"Claes","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cca.2018.05.057_bb0305","first-page":"317","article-title":"Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study","volume":"22","author":"Koos","year":"2013","journal-title":"J. Heart Valve Dis."},{"issue":"8","key":"10.1016\/j.cca.2018.05.057_bb0310","doi-asserted-by":"crossref","first-page":"F1136","DOI":"10.1152\/ajprenal.00684.2011","article-title":"In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt\/\u03b2-catenin activation","volume":"303","author":"Mart\u00ednez-Moreno","year":"2012","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0315","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/ATVBAHA.111.237834","article-title":"Transglutaminase 2\u2013mediated activation of \u03b2-catenin signaling has a critical role in warfarin-induced vascular calcification","volume":"32","author":"Beazley","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2009.09.006","article-title":"High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression","volume":"46","author":"Rom\u00e1n-Garc\u00eda","year":"2010","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0325","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.110.234278","article-title":"The regulation of valvular and vascular sclerosis by osteogenic morphogens","volume":"109","author":"Bostr\u00f6m","year":"2011","journal-title":"Circ. Res."},{"issue":"6655","key":"10.1016\/j.cca.2018.05.057_bb0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"issue":"7120","key":"10.1016\/j.cca.2018.05.057_bb0335","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0340","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.jrn.2011.10.032","article-title":"Indoxyl sulfate induces nephrovascular senescence","volume":"22","author":"Niwa","year":"2012","journal-title":"J. Ren. Nutr."},{"issue":"6655","key":"10.1016\/j.cca.2018.05.057_bb0345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0350","doi-asserted-by":"crossref","first-page":"F570","DOI":"10.1152\/ajprenal.1982.243.6.F570","article-title":"Effects of metabolic acidosis on PTH and 1, 25 (OH) 2D3 response to low calcium diet","volume":"243","author":"Bushinsky","year":"1982","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0355","doi-asserted-by":"crossref","first-page":"F785","DOI":"10.1152\/ajprenal.1985.248.6.F785","article-title":"Cellular contribution to pH-mediated calcium flux in neonatal mouse calvariae","volume":"248","author":"Bushinsky","year":"1985","journal-title":"American Journal of Physiology-Renal Physiology"},{"key":"10.1016\/j.cca.2018.05.057_bb0360","series-title":"Seminars in dialysis: 2003","first-page":"463","article-title":"RENAL RESEARCH INSTITUTE SYMPOSIUM: Cellular Mechanisms of Bone Resorption Induced by Metabolic Acidosis","author":"Krieger","year":"2003"},{"issue":"7","key":"10.1016\/j.cca.2018.05.057_bb0365","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1359\/jbmr.2003.18.7.1317","article-title":"Metabolic acidosis stimulates RANKL RNA expression in bone through a cyclo-oxygenase-dependent mechanism","volume":"18","author":"Frick","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.cca.2018.05.057_bb0370","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4239\/wjd.v2.i3.41","article-title":"Osteoporosis in diabetes mellitus: possible cellular and molecular mechanisms","volume":"2","author":"Wongdee","year":"2011","journal-title":"World J. Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.cca.2018.05.057_bb0375","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11010-009-0344-6","article-title":"High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP\/protein kinase A\/extracellular signal-regulated kinase pathway","volume":"338","author":"Wang","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.cca.2018.05.057_bb0380","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1523-1755.1998.00080.x","article-title":"Hypokinetic azotemic osteodystrophy","volume":"54","author":"Cannata-And\u00eda","year":"1998","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0385","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/009841096161122","article-title":"Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney","volume":"48","author":"Jeffery","year":"1996","journal-title":"J. Toxicol. Environ. Health A"},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0390","first-page":"481","article-title":"Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis","volume":"107","author":"Faugere","year":"1986","journal-title":"J. Lab. Clin. Med."},{"issue":"4","key":"10.1016\/j.cca.2018.05.057_bb0395","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/oxfordjournals.ndt.a027356","article-title":"Frequency of adynamic bone disease and aluminium storage in Italian uraemic patients\u2014retrospective analysis of 1429 iliac crest biopsies","volume":"11","author":"Ballanti","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.cca.2018.05.057_bb0400","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00198-011-1781-0","article-title":"Fracture risk assessment in patients with chronic kidney disease","volume":"23","author":"Jamal","year":"2012","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0405","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2014a single-center cohort study","volume":"27","author":"Iimori","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.cca.2018.05.057_bb0410","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3945\/ajcn.112.036418","article-title":"Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy","volume":"97","author":"Kovesdy","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.cca.2018.05.057_bb0415","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1017\/S0007114513004091","article-title":"Supplementation of ketoacids contributes to the up-regulation of the Wnt7a\/Akt\/p70S6K pathway and the down-regulation of apoptotic and ubiquitin\u2013proteasome systems in the muscle of 5\/6 nephrectomised rats","volume":"111","author":"Wang","year":"2014","journal-title":"Br. J. Nutr."},{"issue":"10","key":"10.1016\/j.cca.2018.05.057_bb0420","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJM198409063111002","article-title":"The effect of a keto acid\u2013amino acid supplement to a restricted diet on the progression of chronic renal failure","volume":"311","author":"Mitch","year":"1984","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0425","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1744-9987.2010.00891.x","article-title":"Uremic toxins and oral adsorbents","volume":"15","author":"Goto","year":"2011","journal-title":"Ther. Apher. Dial."},{"issue":"1","key":"10.1016\/j.cca.2018.05.057_bb0430","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.jrn.2006.10.007","article-title":"Indoxyl sulfate\u2013lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease","volume":"17","author":"Taki","year":"2007","journal-title":"J. Ren. Nutr."},{"issue":"10","key":"10.1016\/j.cca.2018.05.057_bb0435","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfl311","article-title":"Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats","volume":"21","author":"Iwasaki","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0440","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000096423","article-title":"An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats","volume":"26","author":"Nakagawa","year":"2006","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cca.2018.05.057_bb0445","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/ki.2009.400","article-title":"Beyond phosphate binding: the effect of binder therapy on novel biomarkers may have clinical implications for the management of chronic kidney disease patients","volume":"76","author":"Striker","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2018.05.057_bb0450","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/637065","article-title":"Vascular calcification and renal bone disorders","volume":"2014","author":"Lu","year":"2014","journal-title":"Sci. World J."},{"issue":"10","key":"10.1016\/j.cca.2018.05.057_bb0455","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0460","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/1744-9987.12307","article-title":"Effects of uremic toxins from the gut microbiota on bone: a brief look at chronic kidney disease","volume":"19","author":"Black","year":"2015","journal-title":"Ther. Apher. Dial."},{"issue":"11","key":"10.1016\/j.cca.2018.05.057_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076838","article-title":"Does the adequacy parameter kt\/vurea reflect uremic toxin concentrations in hemodialysis patients?","volume":"8","author":"Eloot","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cca.2018.05.057_bb0470","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ki.2015.255","article-title":"Probiotics and chronic kidney disease","volume":"88","author":"Koppe","year":"2015","journal-title":"Kidney Int."},{"issue":"suppl_2","key":"10.1016\/j.cca.2018.05.057_bb0475","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1111\/j.1753-4887.2008.00104.x","article-title":"Vitamin D: a D-Lightful health perspective","volume":"66","author":"Holick","year":"2008","journal-title":"Nutr. Rev."},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0480","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ki.2010.17","article-title":"Vitamin D: a pleiotropic hormone","volume":"78","author":"Verstuyf","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2018.05.057_bb0485","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2015.08.011","article-title":"Vitamin D and immune function in chronic kidney disease","volume":"450","author":"Liu","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cca.2018.05.057_bb0490","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/nu10020196","article-title":"Cholecalciferol additively reduces serum parathyroid hormone levels in severe secondary hyperparathyroidism treated with calcitriol and cinacalcet among hemodialysis patients","volume":"10","author":"Zheng","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.cca.2018.05.057_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.11.029","article-title":"Pleiotropic effects of vitamin D in chronic kidney disease","volume":"453","author":"Liu","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.cca.2018.05.057_bb0500","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2018.05.057_bb0505","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6217286","article-title":"Sclerostin antibody therapy for the treatment of osteoporosis: clinical prospects and challenges","volume":"2016","author":"MacNabb","year":"2016","journal-title":"J. Osteoporos."},{"issue":"3","key":"10.1016\/j.cca.2018.05.057_bb0510","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.2372","article-title":"Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy","volume":"30","author":"Moe","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.cca.2018.05.057_bb0515","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.2372","article-title":"Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy","volume":"30","author":"Moe","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"15","key":"10.1016\/j.cca.2018.05.057_bb0520","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118302754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118302754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T22:43:17Z","timestamp":1661380997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898118302754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":104,"alternative-id":["S0009898118302754"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.05.057","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of uremic toxin-indoxyl sulfate on the skeletal system","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.05.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}